Our team at AbleLeaf strives to ensure our consumers understand all there is to know about CBD Oil. It is important to know the difference between the many products and how most other company’s promote CBD as some sort of “Miracle Oil” that will heal ailments and cure everything from the common cold to cancer. Unfortunately this is not the case. CBD Oil does not cure ailments. That is a myth and just not factual.
Cannabidiol (CBD) is a type of cannabinoid, a chemical found naturally in cannabis (marijuana and hemp) plants. CBD doesn’t cause any feelings of intoxication or the “high” you may associate with cannabis from tetrahydrocannabinol (THC), which is another type of cannabinoid altogether.
HOW IT WORKS
The human body has many different receptors. Receptors are protein-based chemical structures that are attached to your cells. They receive signals from different stimuli.
CBD is thought to interact with CB1 and CB2 receptors. These receptors are mostly found in the central nervous system and the peripheral nervous system, respectively.
The exact way CBD affects CB1 receptors in the brain isn’t fully understood. However, it may alter serotonin signals.
Serotonin, a neurotransmitter, plays an important role in your mental health. Low serotonin levels are commonly associated with people who have depression. In some cases, not having enough serotonin may also cause anxiety.
The conventional treatment for low serotonin is a selective serotonin reuptake inhibitor (SSRI), such as sertraline (Zoloft) or fluoxetine (Prozac). SSRIs are only available by prescription.
Some people with anxiety may be able to manage their condition with CBD instead of an SSRI. However, you should talk to your doctor before making changes to your treatment plan.
If you’re interested in trying CBD oil for your anxiety, talk to your doctor. They can help you figure out a starting dosage that’s right for you.
However, the nonprofit National Organization for the Reform of Marijuana Laws (NORML) does advise that very few commercially available products contain enough CBD to replicate the therapeutic effects seen in clinical trials.
In a 2018 study, male subjects received CBD before undergoing a simulated public speaking test. The researchers found that an oral dose of 300 mg, administered 90 minutes before the test, was enough to significantly reduce the speakers’ anxiety.
Members of the placebo group and study subjects who received 150 mg saw little benefit. The same was true for subjects who received 600 mg.
The study only looked at 57 subjects, so it was small. More research, including studies that look at female subjects, is needed to determine the appropriate dosage for people with anxiety.